AYDOĞDU, M. Et Al. 2013. The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients. DISEASE MARKERS , vol.34, no.4 , 237-246.

AYDOĞDU, M., GÜRSEL, G., Sancak, B., Yeni, S., Sari, G., Tasyurek, S., ... Turk, M.(2013). The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients. DISEASE MARKERS , vol.34, no.4, 237-246.

AYDOĞDU, MÜGE Et Al. "The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients," DISEASE MARKERS , vol.34, no.4, 237-246, 2013

AYDOĞDU, MÜGE Et Al. "The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients." DISEASE MARKERS , vol.34, no.4, pp.237-246, 2013

AYDOĞDU, M. Et Al. (2013) . "The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients." DISEASE MARKERS , vol.34, no.4, pp.237-246.

@article{article, author={MÜGE AYDOĞDU Et Al. }, title={The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients}, journal={DISEASE MARKERS}, year=2013, pages={237-246} }